Your session is about to expire
Suboxone vs Tramadol
Introduction
For patients grappling with opioid dependency or chronic pain, specific medications that interact with the opioid receptors in the brain can help manage withdrawal symptoms and provide relief. Suboxone and Tramadol are two such drugs primarily prescribed for these conditions. They each impact different aspects of opioid receptor activity but both have effects in reducing discomfort and dependency symptoms.
Suboxone is a combination medication composed of buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist; it acts by blocking other opioids while also decreasing cravings and withdrawal symptoms.
Tramadol on the other hand is classified as an atypical centrally-acting analgesic that has mu-opioid agonist activity and inhibits reuptake of norepinephrine and serotonin to increase their levels. It doesn't block other opioids from acting on the receptors like Suboxone does but is used to treat moderate to severe pain.
Suboxone vs Tramadol Side By Side
| Attribute | Suboxone | Tramadol |
|---|---|---|
| Brand Name | Suboxone | Tramadol |
| Contraindications | Should not be taken with MAO inhibitors or by patients with a history of narcotic dependency without medical supervision due to high abuse potential. | Should not be used with MAO inhibitors or by patients under 17 without specific medical advice. Caution in patients with a history of narcotic dependency. |
| Cost | For brand name: around $154 for 30 sublingual tablets (2 mg/0.5 mg). For generic: approximately $1 - $3 per day depending on dosage. | For brand name: approximately $125 for 60 tablets (50 mg). For generic: starts at about $.20/.40 cents per day and doesn't exceed about $.80/$1.00 per day. |
| Generic Name | Buprenorphine/Naloxone | Tramadol |
| Most Serious Side Effect | Respiratory distress, severe allergic reactions, liver problems, opioid withdrawal symptoms, weakness, slurred speech, balance problems. | Serotonin syndrome, severe allergic reactions, severe skin reactions, changes in consciousness, unusual behavior changes, seizure. |
| Severe Drug Interactions | Risk of respiratory distress when combined with other CNS depressants, potential for serotonin syndrome with serotonergic drugs. | Increased risk of serotonin syndrome with serotonergic drugs, risk of seizures with drugs that lower the seizure threshold, potential for respiratory depression when combined with CNS depressants. |
| Typical Dose | 4 mg/1mg to 24 mg/6mg per day, with 16 mg/4mg being sufficient for most people. | 50-100 mg/day initially, up to 200 mg/day. For severe pain, up to 400 mg/day. |
What is Suboxone?
Suboxone (a combination of buprenorphine and naloxone) and Tramadol are both used for pain management, but they belong to different classes of medication. Suboxone is an opioid medication that was first approved by the FDA in 2002. It works by binding to the same receptors as other opioids do, effectively reducing cravings and withdrawal symptoms associated with opioid addiction. This makes it a commonly used drug in the treatment of opioid dependence.
On the contrary, Tramadol is an atypical analgesic that has some weak µ-opioid receptor agonist properties along with inhibitory effects on serotonin-norepinephrine reuptake; thus making it effective in managing moderate to severe acute or chronic pain. Although tramadol has fewer side effects than traditional opioids due to its unique mechanism of action, care must be taken because tramadol can still cause physical dependency if misused or overused.
In conclusion, while both Suboxone and Tramadol are potent drugs for treating pain-related conditions, their mechanisms differ significantly: Suboxone primarily serves as a tool against opioid addiction whereas Tramadol functions more traditionally as an analgesic.
What conditions is Suboxone approved to treat?
Suboxone and Tramadol are both approved for different uses by the FDA:
- Suboxone is primarily used in medication-assisted therapy (MAT) to help people reduce or quit their use of heroin or other opiates such as pain relievers like morphine.
- Tramadol, on the other hand, is a potent analgesic used for treating moderate to severe pain. It can be prescribed following surgery or injury, or for conditions such as cancer-related pain.
How does Suboxone help with these illnesses?
Suboxone aids in managing opioid dependence by combining buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist. Buprenorphine binds to the same receptors as other opioids but produces less euphoric effects, thus helping to reduce cravings and withdrawal symptoms. Naloxone is included to deter abuse of the medication; if Suboxone were injected rather than taken orally as directed, naloxone would precipitate immediate withdrawal symptoms.
Tramadol works differently: it not only has weak opioid action but also inhibits reabsorption of two important neurotransmitters in pain modulation - serotonin and norepinephrine. This dual mode of action sets Tramadol apart from other traditional opioids. However, unlike Suboxone which is used for treating addiction, Tramadol itself can be addictive and must be used with caution.
Both options work on the brain's response system related to pleasure and pain relief however they serve different purposes - one helps manage chronic or acute pain while the other assists patients in overcoming their addiction issues.
What is Tramadol?
Tramadol, frequently sold under the brand name Ultram, is an opioid pain medication used to treat moderate to moderately severe pain. It operates by acting on the central nervous system to change how your body feels and responds to pain. Tramadol can either be a full-on opioid or it could act as a serotonin-norepinephrine reuptake inhibitor (SNRI), implying that it increases levels of serotonin and norepinephrine in the brain by reducing their reabsorption. This dual-action mechanism may give tramadol an edge over other opioids for some individuals.
Tramadol was first approved by the FDA in 1995, making it newer than many other opioid medications. Its distinctive characteristics mean that its side-effect profile differs from those of typical opioids like Suboxone because while most opioids cause sedation, weight gain and sexual dysfunction, these side effects are less common with Tramadol use due to its SNRI properties.
However, just like any medication, tramadol has potential risks including dependency and withdrawal symptoms upon discontinuation after long-term use; hence should always be taken as advised by a healthcare provider. The unique dual action effect on both opioid receptors and reuptake inhibition makes Tramadol beneficial for certain types of chronic pain where traditional opioids or antidepressants alone are not effective.
What conditions is Tramadol approved to treat?
Tramadol is endorsed for the treatment of moderate to severe pain, whether it's acute or chronic. It is also used in managing pain after surgery. Here are some conditions that Tramadol can be used for:
- Postoperative pain
- Osteoarthritis
- Neuropathic Pain
- Chronic musculoskeletal pain
How does Tramadol help with these illnesses?
Tramadol is a potent pain reliever that acts on the central nervous system to change how your body feels and responds to pain. It works by binding to opioid receptors in the brain, which are involved in transmitting the sensation of pain from throughout the body back to the brain. Like norepinephrine, it plays significant roles in various bodily functions including mood regulation and response to stress. Unlike Suboxone, which is typically used as part of a complete treatment plan for drug abuse (such as compliance monitoring or counseling), Tramadol's primary use is for relieving severe ongoing pain like that caused by conditions such as fibromyalgia. Its function on serotonin levels also gives it antidepressant properties, thereby making it suitable for patients whose depression symptoms have not responded well to typical SSRI medications or may need combination therapy.
How effective are both Suboxone and Tramadol?
Both Suboxone (buprenorphine/naloxone) and tramadol have established histories of success in managing pain, with the former also being used as a treatment for opioid dependence. They were first approved by the FDA in 1981 and 2002 respectively, acting on different receptors within the central nervous system. A double-blind clinical trial comparing Suboxone to tramadol hasn't been conducted; however, separate studies indicate that both drugs can be effective in their specific applications.
Suboxone is a combination medication containing buprenorphine (a partial opioid agonist) and naloxone (an antagonist), designed to treat opioid use disorder while minimizing potential misuse. Its unique formulation allows it to suppress withdrawal symptoms associated with discontinuing opioids without providing the euphoria commonly associated with these substances.
Tramadol on the other hand is a centrally acting analgesic used for treating moderate to severe pain. It works by binding to μ-opioid receptors and inhibiting reuptake of norepinephrine and serotonin, thereby reducing pain perception but also has potential for abuse due its opiate-like effects.
A meta-analysis conducted in 2014 concluded that Buprenorphine/Naloxone (Suboxone) was more effective than placebo at retaining people in treatment and suppressing illicit opiate use. The optimal dosage appears variable among individuals, often requiring adjustments under medical supervision.
While Tramadol's efficacy as an analgesic has been demonstrated across many types of acute and chronic pain conditions over several decades now, it should be noted that because Tramadol acts similarly to opioids there are risks associated such as dependency or overdose especially when not taken correctly or abused.
Related trials for suboxone and tramadol
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Suboxone typically prescribed?
Oral dosages of Suboxone for opioid dependence start at 4 mg/1mg buprenorphine/naloxone up to 24 mg/6mg per day, but research indicates that a dose of 16 mg/4mg is sufficient for most people. Children and adolescents should not use this medication unless specifically directed by their healthcare provider. In adults, the dosage may be adjusted after a few weeks if there is no response or if withdrawal symptoms persist. The maximum dosage that should not be exceeded in any case is 24 mg/6mg per day.
On the other hand, Tramadol doses range from 50–400 mg/day depending on the severity of pain. For chronic pain management in adults, it usually starts with immediate-release tablets every four to six hours as needed with an initial dose of 25-100mg per day gradually increased by 25-50mg every three days until relief is achieved. Maximum daily dose should not exceed 400mgs. Due to its potential risks including addiction and overdose, it's generally not recommended for children and adolescents under age seventeen without specific medical advice.
At what dose is Tramadol typically prescribed?
Tramadol treatment is typically initiated at a dose of 50-100 mg/day. This can be increased by your doctor to 200 mg/day divided into two doses, approximately twelve hours apart. For severe pain management, the maximum dosage might reach up to 400 mg/day divided into four doses of 100 mg each and spaced six hours apart. This should only be attempted if there's no sufficient response to lower dosages after an appropriate duration of time, generally a few weeks. Always consult with your healthcare provider before making any changes to your medication regimen.
What are the most common side effects for Suboxone?
Some of the common side effects of Suboxone include:
- Nausea
- Vomiting
- Drug withdrawal syndrome
- Headache
- Sweating
- Numb mouth
- Constipation
- Painful tongue
- Redness in the mouth
- Intoxication (feeling lightheaded or drunk) -Fainting, dizziness, or feeling dizzy when getting up from sitting or lying down.
While Tramadol is associated with the following potential side effects:
-Nausea and vomiting. -Agitation, nervousness, anxiety. -Drowsiness and insomnia. -Increased heart rate. -Diarrhea, constipation and stomach discomfort. -Sweating a lot more than usual.
Are there any potential serious side effects for Suboxone?
While both Suboxone and Tramadol are used to manage pain, they carry different risks. Serious side effects of Suboxone can include:
- Respiratory distress or severe breathing problems
- Signs of an allergic reaction such as hives, difficulty in breathing, swelling in your face or throat
- Liver problems; symptoms might include nausea, upper stomach pain, tiredness, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes)
- Opioid withdrawal symptoms - shivering, goosebumps, increased sweating, feeling hot or cold
- Weakness especially on one side of the body
- Slurred speech
- Problems with balance
Similarly serious side effects from using Tramadol could be:
- Serotonin syndrome: agitation hallucinations fever overactive reflexes fast heart rate nausea vomiting diarrhea loss of coordination fainting.
In either case if you experience any such serious side effects seek immediate medical attention.
What are the most common side effects for Tramadol?
Common side effects of Tramadol include:
- Nausea, vomiting, loss of appetite
- Dizziness or lightheadedness
- Constipation
- Headache
- Drowsiness, fatigue
- Dry mouth
- Sweating While more serious but less common side effects may encompass rapid heartbeat and feelings of agitation. It's important to note that each person is unique and may respond differently to medication. Always consult with your healthcare provider for personalized advice based on your health situation.
Are there any potential serious side effects for Tramadol?
While Tramadol is often an effective choice for pain management, it can also cause serious side effects in rare cases. Users should be alert to the following potential symptoms:
- Signs of allergic reactions such as hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
- Indications of serotonin syndrome: agitation, hallucinations (hearing or seeing things that are not real), fast heart rate, high body temperature, overactive reflexes, nausea/vomiting/diarrhea.
- Severe skin reactions like itching and peeling rash.
- Any changes in consciousness including severe drowsiness or fainting spells.
- Unusual behavior changes such as confusion or mood swings
- A seizure (convulsions).
- Symptoms related to adrenal insufficiency like loss of appetite, fatigue and weakness.
If you experience any of these symptoms while taking Tramadol, seek immediate medical attention.
Contraindications for Suboxone and Tramadol?
Both Suboxone and Tramadol, along with most other opioid medications, may worsen symptoms of depression in some people. If you notice your depression worsening or an increase in suicidal ideation, thoughts, or behavior after starting these medications, please seek immediate medical attention.
Neither Suboxone nor Tramadol should be taken if you are currently using, or have recently discontinued a monoamine oxidase (MAO) inhibitor. Always tell your healthcare provider about all the medications you're taking; MAO inhibitors need approximately two weeks to clear from your system to avoid harmful interactions with both Suboxone and Tramadol.
Additionally, patients who are dependent on narcotics should not use tramadol due to its potential for addiction and withdrawal issues. On the other hand, suboxone is specifically designed to help those addicted to opioids quit their drug habit but it must be used under strict doctor supervision as it also has high abuse potential.
How much do Suboxone and Tramadol cost?
For the brand name versions of these drugs:
- The price of 30 sublingual tablets of Suboxone (2 mg/0.5 mg) averages around $154, which works out to about $5–$10/day depending on your dose.
- The price for 60 tablets of Tramadol (50 mg) is approximately $125, working out to be roughly $2-$4/day.
If you are in the higher dosage range for Suboxone (i.e., 16 mg/day or higher), then brand-name Tramadol is less expensive on a per-day treatment basis. However, cost should not be the primary consideration in determining which medication is right for you; efficacy and safety must also be considered.
For generic versions of Suboxone (buprenorphine/naloxone) and Tramadol, costs can be significantly lower:
- Buprenorphine/Naloxone (2mg/0.5mg tablets) tends to come in packs from 14 up to100 with approximate costs ranging between $1 - $3 per day depending on dosages from 2mg up to a more typical daily dosage range of 8 -12mg.
- Generic tramadol is available in packs from as low as 20 capsules all the way up to enormous quantities like bottles containing thousands. Costs start at an affordable rate like $.20/.40 cents per day when purchased upfront and don't exceed about $.80/$1.00 per day even at standard therapeutic doses such as two or three times daily administration using either immediate-release tramadol products or once-daily extended-release formulations respectively.
Popularity of Suboxone and Tramadol
Suboxone, a combination of buprenorphine and naloxone, was estimated to have been prescribed to about 3 million people in the US in 2020. Suboxone is mainly used as a substitute therapy for opioid addiction and accounted for just over 30% of prescriptions for this purpose. It has become an increasingly prevalent choice since its introduction in the early 2000s due to its ability to reduce withdrawal symptoms without producing the high associated with opioid misuse.
On the other hand, Tramadol, sold under various brand names such as Ultram or Conzip, was prescribed to nearly 14 million Americans in 2020. This drug belongs to the class of opioids and is commonly used for moderate-to-severe pain management. In recent years it accounted for about 10% of all opioid prescriptions written across different medical specialties. Despite rising controversies related to potential abuse, dependence issues and increased regulatory scrutiny on prescribing patterns by healthcare providers; tramadol's prescription numbers remained relatively steady throughout most of last decade.
Conclusion
Suboxone (buprenorphine/naloxone) and Tramadol are two different medications used in the management of chronic pain. They have a well-established record of use, supported by clinical studies showing they are more effective than placebo treatments. Suboxone is primarily used for opioid dependency treatment due to its unique combination of buprenorphine, which is an opioid, and naloxone that prevents misuse. On the other hand, Tramadol is often prescribed as a moderate-to-severe pain reliever.
The mechanisms of action for both drugs differ significantly; Suboxone works on mu-opioid receptors while limiting euphoria commonly associated with opioids through the presence of naloxone; tramadol acts on multiple neurotransmitters including serotonin and norepinephrine along with mu-opioid receptors without any deterrent component.
Both medications come in generic forms, offering cost-effective solutions for patients needing out-of-pocket purchases. The effects may not be immediately noticeable requiring some adaptation period.
Side effects between these two drugs vary considerably due to their different properties: common side effects with Suboxone can include nausea, headache and constipation whereas tramadol might cause dizziness, sleepiness or vomiting. Patients using either medication should remain vigilant about changes in their condition and consult with medical professionals if new symptoms develop or existing ones worsen.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Tagarro, I., Herrera, J., Barutell, C., D??ez, M. C., Mar??n, M., Samper, D., … Rodr??guez, M. J. (2005). Effect of a Simple Dose-Escalation Schedule on Tramadol Tolerability. Clinical Drug Investigation. Springer Science and Business Media LLC.http://doi.org/10.2165/00044011-200525010-00003
- Mori, F., Barni, S., Manfredi, M., Sarti, L., Pecorari, L., Pucci, N., & Novembre, E. (2015). Anaphylaxis to Intravenous Tramadol in a Child. Pharmacology. S. Karger AG.http://doi.org/10.1159/000441005
- Chawla, MD, J. M., Pal, MD, H., Lal, MD, R., Jain, PhD, R., Schooler, PhD, N., & Balhara, MD, Y. P. S. (2013, January 1). Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects. Journal of Opioid Management. Weston Medical Publishing.http://doi.org/10.5055/jom.2013.0145
- Greenwald, M. K., Comer, S. D., & Fiellin, D. A. (2014, November). Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: Implications for clinical use and policy. Drug and Alcohol Dependence. Elsevier BV.http://doi.org/10.1016/j.drugalcdep.2014.07.035
- Duke, A. N., Bigelow, G. E., Lanier, R. K., & Strain, E. C. (2011, April 5). Discriminative Stimulus Effects of Tramadol in Humans. Journal of Pharmacology and Experimental Therapeutics. American Society for Pharmacology & Experimental Therapeutics (ASPET).http://doi.org/10.1124/jpet.111.181131
- Montalvo, C., Genovese, N., & Renner, J. (2019, April). The Problem of Pain: Additive Analgesic Effect of Tramadol and Buprenorphine in a Patient with Opioid use Disorder. Substance Abuse. SAGE Publications.http://doi.org/10.1080/08897077.2019.1572050
- Threlkeld, T., Parran, T. V., Jr., Adelman, C. A., Grey, S. F., & Yu, Y. (2006, March 4). Tramadol versus Buprenorphine for the Management of Acute Heroin Withdrawal: A Retrospective Matched Cohort Controlled Study. The American Journal on Addictions. Wiley.http://doi.org/10.1080/10550490500528712
- Orman, J. S., & Keating, G. M. (2009). Buprenorphine/Naloxone. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-200969050-00006
- Staunstrup, H., Ovesen, J., Larsen, U. T., Elbæk, K., Larsen, U., & Krøner, K. (1999, August). Efficacy and Tolerability of Lornoxicam versus Tramadol in Postoperative Pain. The Journal of Clinical Pharmacology. Wiley.http://doi.org/10.1177/00912709922008362
- Orman, J. S., & Keating, G. M. (2009). Buprenorphine/Naloxone. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-200969050-00006